Results 21 to 30 of about 805,395 (207)
Detection of SARS-CoV-2 in Different Types of Clinical Specimens.
Journal of the American Medical Association (JAMA), 2020 This study describes results of PCR and viral RNA testing for SARS-CoV-2 in bronchoalveolar fluid, sputum, feces, blood, and urine specimens from patients with COVID-19 infection in China to identify possible means of non-respiratory transmission.
Wenling Wang +6 more
semanticscholar +1 more source
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Science, 2021 Variable memory Immune memory against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) helps to determine protection against reinfection, disease risk, and vaccine efficacy.
J. Dan +20 more
semanticscholar +1 more source
Characteristics of SARS-CoV-2 and COVID-19
Nature Reviews Microbiology, 2020 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019 and has caused a pandemic of acute respiratory disease, named ‘coronavirus disease 2019’ (COVID-19), which ...
Ben Hu, Hua Guo, P. Zhou, Zhènglì Shí
semanticscholar +1 more source
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Science, 2021 UK variant transmission Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has the capacity to generate variants with major genomic changes. The UK variant B.1.1.7 (also known as VOC 202012/01) has many mutations that alter virus attachment and
N. Davies +22 more
semanticscholar +1 more source
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients
New England Journal of Medicine, 2020 SARS-CoV-2 Viral Load in Upper Respiratory Specimens The authors report results of an analysis of nasal and throat swabs from 17 patients in Zhuhai, China, who had received a diagnosis of Covid-19....
L. Zou +15 more
semanticscholar +1 more source
A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing
Nature, 2020 A newly described coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of coronavirus disease 2019 (COVID-19), has infected over 2.3 million people, led to the death of more than 160,000 individuals
D. Gordon +124 more
semanticscholar +1 more source
SARS-CoV-2 variants, spike mutations and immune escape
Nature Reviews Microbiology, 2021 Although most mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome are expected to be either deleterious and swiftly purged or relatively neutral, a small proportion will affect functional properties and may alter ...
William T. Harvey +10 more
semanticscholar +1 more source
Mechanisms of SARS-CoV-2 entry into cells
Nature reviews. Molecular cell biology, 2021 The unprecedented public health and economic impact of the COVID-19 pandemic caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been met with an equally unprecedented scientific response.
C. B. Jackson +3 more
semanticscholar +1 more source
Cardiovascular disease in SARS‐CoV‐2 infection
Clinical & Translational Immunology, 2021 Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection can also trigger de novo acute and chronic cardiovascular disease.
Kei Sato +5 more
doaj +1 more source
Racing for a SARS‐CoV‐2 vaccine
EMBO Molecular Medicine, 2021 Graphical Abstract Interview with EMBO Members Özlem Türeci and Uğur Şahin, BioNTech, conducted by science journalist Kai Kupferschmidt.
Özlem Türeci, Uğur Şahin
doaj +1 more source